Navigation Links
Beanstalk Capital Ltd. enters into arrangement agreement with iCo Therapeutics Inc.
Date:10/16/2007

as chief scientific officer in July 2005. Dr. Ono also acts as Vice Provost for Academic Initiatives and Deputy to the Provost at Emory University. From 2001 to 2006, Professor Ono served as the Cumberlege Professor of Biomedical Science and as the GlaxoSmithKline Professor of Ocular Immunology at the University College London from 2001 to 2006. Professor Ono also served as the Chair of Immunology at the University College London/Moorfields Eye Hospital Institute of Ophthalmology (the world's first and largest eye research and treatment centre). Past appointments include Assistant Professor of Medicine, Pathology & Biology at Johns Hopkins University, and Associate Professor & Director of the Immunity, Inflammation and Transplantation Group at the Schepens Eye Research Institute, Harvard Medical School. Professor Ono has directed multiple research and development programs, many of which have been in partnership with biotechnology and pharmaceutical companies. He serves on many editorial boards, is involved with numerous professional societies and associations, and has more than eighty publications to his credit. Among his many honours, he was elected International Fellow of the American Academy of Asthma, Allergy and Immunology, Fellow of the Royal Society of Medicine, and received the Pharmacia International Award in Allergy Research. Professor Ono received a Bachelor of Arts from the University of Chicago, his PhD from McGill University and was a Helen Hay Whitney Fellow at Harvard University.

Significant Conditions to Closing

Completion of the transaction is subject to a number of conditions including, without limitation, approval by iCo's shareholders, approval of the Supreme Court of British Columbia and the TSX Venture Exchange, and completion by Beanstalk of a private placement of equity securities having a minimum aggregate subscription price of $1,802,500. There can be no assurance that the transaction will be completed as proposed or at all.'/>"/>

SOURCE Beanstalk Capital Ltd.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine news :

1. Gay capital reeling with rising HIV infection
2. Drugs Manufacturers Capitalizing On The Surge In Demand For Bone Health Care
3. Meningitis is rocking the capital again
4. India Crowned As the Diabetic Capital
5. China Crowned the Diabetic Capital of the World
6. Low Awareness Of Kawasaki Disease In Capital: Parents Form Support Group
7. Zagreb, capital of Croatia, affected by first bird flu case
8. Chikungunya in the Capital
9. Dengue Outbreak in the Capital is not an Epidemic: Government
10. Private Health Clinics in the Capital on Strike
11. Migration is the Cause for Fresh Polio Cases in the Capital: Sheila Dikshit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/4/2015)... ... September 04, 2015 , ... San Francisco ... at CitiDent. CEREC is a newer method for creating restorations through innovative imaging ... by eliminating the need for multiple appointments, CEREC produces restorations with total precision ...
(Date:9/4/2015)... ... 04, 2015 , ... Mike Day, a former Navy SEAL who was shot ... World Championships in Kona on October 10th. , Mike is running the race to ... combat and the cutting-edge treatments that restore their quality of life. More ...
(Date:9/4/2015)... Grants Pass, OR (PRWEB) , ... September 04, ... ... Center that markets a line of personal humidifying medical devices, announced its only ... global climate, explains Bio-Logic Aqua® Research Founder Sharon Kleyne, body water evaporation is ...
(Date:9/4/2015)... ME (PRWEB) , ... September 04, 2015 , ... ... focus on: the microbiome taking place in Hollywood, Florida October 9-10, 2015 at ... , Speakers at the 2015 symposium are doctors and researchers at the top ...
(Date:9/4/2015)... Seattle, Washington (PRWEB) , ... September 04, 2015 ... ... the design and development of its first neighborhood created specifically for adults with ... located in the Phoenix Metro area and feature 30 cottage or “pocket” homes. ...
Breaking Medicine News(10 mins):Health News:San Francisco Dentist, Dr. Ben Amini, is Now Offering CEREC Technology at CitiDent 2Health News:Navy SEAL Shot 27 Times Competes in Ironman World Championship in Kona to Raise Money for Veteran's Suffering from TBI and PTSD 2Health News:Bio-Logic Aqua® Research Announces Water Life Science and Body Water Evaporation as Research Focus and Mission 2Health News:Bio-Logic Aqua® Research Announces Water Life Science and Body Water Evaporation as Research Focus and Mission 3Health News:Integrative Healthcare Symposium Focus On: The Microbiome Conference Program Announced 2Health News:Cottage Home Communities for Disabled Adults to Create First Viable Permanent Housing Option 2Health News:Cottage Home Communities for Disabled Adults to Create First Viable Permanent Housing Option 3Health News:Cottage Home Communities for Disabled Adults to Create First Viable Permanent Housing Option 4
... 65 Total Sponsors: Covidien, Johnson & Johnson, Ernst ... WASHINGTON, Sept. 22 AdvaMed 2008,s list of,sponsors ... and government agencies including the Ontario Ministry of ... Industrial Development,Company (PRIDCO). The number of sponsors increased ...
... with Social Security Disability Insurance as population ages; though disability ... , ... Belleville, Ill.(Vocus) September 22, ... retirement age, an echoing wave of the working population is ...
... multi unit CR installation at Thu Duc district Hospital. Two new ... in the new Computed Radiography room in the Radiology department of the ... ... Torrance, Calif. (PRWEB) September 20, 2008 -- iCRco Inc. with Coastal Medical ...
... Today, more people can learn,about the life-saving benefits ... Produced by the Plasma Protein Therapeutics,Association (PPTA), this ... it helps patients with chronic, life-threatening,diseases, and will ... center., PPTA designed this informative site in ...
... often not started among middle-aged men, study finds , , FRIDAY, ... start treatment of middle-aged men with high blood pressure when ... the study happened to be black, but the same is ... who was expected to report the findings Friday at the ...
... as Guest Editor for a special issue of The Monitor, journal ... in Clinical Research. , ... St. Petersburg, FL (PRWEB) ... journal of the Association of Clinical Research Professionals (ACRP), is dedicated ...
Cached Medicine News:Health News:AdvaMed 2008 Sponsor Participation Increases by 52% 2Health News:AdvaMed 2008 Sponsor Participation Increases by 52% 3Health News:AdvaMed 2008 Sponsor Participation Increases by 52% 4Health News:Baby Boomers' Aging Wave Affects Social Security Disability Program 2Health News:Baby Boomers' Aging Wave Affects Social Security Disability Program 3Health News:Baby Boomers' Aging Wave Affects Social Security Disability Program 4Health News:Baby Boomers' Aging Wave Affects Social Security Disability Program 5Health News:iCRco Lands CR Contract with Thu Duc District Hospital in Vietnam 2Health News:PPTA Launches New Educational Website on Donating Plasma 2Health News:Many Doctors Don't Know Blood Pressure Guidelines 2Health News:GetResearchSmart LLC Website Founder Honored as Guest Editor 2
(Date:9/4/2015)... , Sept. 4, 2015 Physician E-sampling is ... and has become a key marketing sales tactic in ... fully adopt E-sampling as a supplement to traditional sampling. ... Best Practices, LLC, physician E-sampling has been seeded across ... chronic areas. While E-sampling has been in place for ...
(Date:9/4/2015)... -- Janssen Research & Development, LLC (Janssen) announced today ... accepted for Priority Review the Biologics License Application ... with multiple myeloma who are refractory to both ... (IMiD), or who have received three or more ... an IMiD. This is referred to as "double ...
(Date:9/4/2015)... Fair Rate Funding, a lawsuit funding firm located in ... in lawsuit filings in connection with the blood thinning drug, ... Philadelphia Court of Common Pleas has risen ... Louisiana multi---district litigation (MDL), located in the ... Louisiana , the filings are also on the rise, ...
Breaking Medicine Technology:Current and Future Trends in Physician E-Sampling Programs for the Pharmaceutical Industry 2U.S. FDA Grants Priority Review to Janssen for Daratumumab as a Treatment for Multiple Myeloma 2U.S. FDA Grants Priority Review to Janssen for Daratumumab as a Treatment for Multiple Myeloma 3U.S. FDA Grants Priority Review to Janssen for Daratumumab as a Treatment for Multiple Myeloma 4U.S. FDA Grants Priority Review to Janssen for Daratumumab as a Treatment for Multiple Myeloma 5U.S. FDA Grants Priority Review to Janssen for Daratumumab as a Treatment for Multiple Myeloma 6U.S. FDA Grants Priority Review to Janssen for Daratumumab as a Treatment for Multiple Myeloma 7Xarelto Lawsuit Funding Firm, Fair Rate Funding Reports a Steady Rise in Xarelto Product Liability Lawsuit Filings 2Xarelto Lawsuit Funding Firm, Fair Rate Funding Reports a Steady Rise in Xarelto Product Liability Lawsuit Filings 3
... April 9, 2008 Dutch biotechnology,company Crucell N.V., ... South,African Tuberculosis Vaccine Initiative (SATVI) present a progress ... tuberculosis vaccine study at the,biennial "Tuberculosis Vaccines for ... today. The study, conducted in Worcester, South,Africa and ...
... NEW YORK, April 9, 2008 Intra-Cellular ... its ongoing development,programs for ITI-007, the Company,s ... (DPPM), and ITI-722,a low-dose formulation of ITI-007, ... disorders, respectively. These new data demonstrate,ITI-007 has ...
Cached Medicine Technology:Aeras, Crucell and South African Tuberculosis Vaccine Initiative Announce Encouraging Preliminary Results of Tuberculosis Vaccine Clinical Trial in South Africa 2Aeras, Crucell and South African Tuberculosis Vaccine Initiative Announce Encouraging Preliminary Results of Tuberculosis Vaccine Clinical Trial in South Africa 3Aeras, Crucell and South African Tuberculosis Vaccine Initiative Announce Encouraging Preliminary Results of Tuberculosis Vaccine Clinical Trial in South Africa 4Aeras, Crucell and South African Tuberculosis Vaccine Initiative Announce Encouraging Preliminary Results of Tuberculosis Vaccine Clinical Trial in South Africa 5Aeras, Crucell and South African Tuberculosis Vaccine Initiative Announce Encouraging Preliminary Results of Tuberculosis Vaccine Clinical Trial in South Africa 6Intra-Cellular Therapies Announces the Discovery of Potent Antidepressant Activity in ITI-007/ITI-722 2Intra-Cellular Therapies Announces the Discovery of Potent Antidepressant Activity in ITI-007/ITI-722 3
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: